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Introduction

★ Caffeine is the most popular psychoactive substance in the world;
approximately 80% of the world’s adult population consumes some form
of caffeine daily1
★ Caffeine imparts improvements to multiple cognitive domains including
information processing, attention, and specific types of memory2-6
★ Caffeine’s cognitive effects have been largely attributed to its
competitive antagonism of the A1 & A2A adenosine receptors7

To investigate the effect of caffeine
consumption on mental fatigue immediately
following a 48-hour caffeine withdrawal period

Hypothesis
The difference in mean reaction time (ms)
between the last five minutes and first five
minutes of PVT (DMRT) following caffeine
consumption will be less than baseline and
placebo.

★ Mental fatigue is a neurological state which manifests as a decline
in mental efficiency and ability, commonly experienced following
periods of sustained attentional or cognitive demand11
★ The Psychomotor Vigilance Task (PVT) has been well-documented
to induce mental fatigue12
★ The present study operationalized the severity of participants’
mental fatigue as their performance on the PVT

★ Withdrawal symptoms (WS), including headache, fatigue, decreased
contentedness, and decreased alertness are experienced by a large
proportion of caffeine consumers8
★ Caffeine administration has been shown to reverse caffeine WS9
★ Daily consumption of 100mg of caffeine has been sufficient to
establish physical dependence, leading to WS upon cessation10
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Methods

Participant Characteristics
Participant ID Age
Sex
(years) M
1
23
M
2
23
M
3
27
M
4
22
F
5
21
F
Mean
23.2
SD
2.3

Week 1
Day 1 of Abstinence

CCQ-R
Vitals (HR, BP)
PVT
Post-PVT Vitals

Day 2 of Abstinence

Day 3 (intervention)

CWSQ
Pre-intervention Vitals
No Lab Visit Required

20-minute
“Absorption
period”

Placebo
administration

Week 2

No Lab Visit Required

Post-intervention
Vitals
CWSQ
PVT

Counter-balanced
CWSQ
Pre-intervention Vitals

20-minute
“Absorption
period”

No Lab Visit Required
CCQ-R-determined
Caffeine
administration

Post-intervention
Vitals
CWSQ
PVT

Caffeine Consumption Questionnaire Revised (CCQ-R), Caffeine Withdrawal Symptom Questionnaire (CWSQ)

Results

Conclusion & Implications
★ The decrease in mean CWSQ following caffeine consumption scores
indicate withdrawal reversal
★ DMRT was greatest in the baseline condition, and visually comparable in
the placebo and caffeine conditions → placebo and caffeine administration
were able to reduce mental fatigue during PVT
★ Our current results suggest that placebo administration may aid in
alleviating withdrawal symptoms and mitigating mental fatigue for those
beginning caffeine abstinence
★ Future studies should investigate whether a dose-response relationship
exists between caffeine and mental fatigue
★ Future studies should investigate other modalities that may mitigate the
deleterious effects of mental fatigue (e.g., exercise, vibration, etc.)
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Figure 1 – This figure depicts mean CWSQ scores in Placebo and Caffeine
conditions. Scores represented as means ± SD.

Figure 2 – This figure depicts the difference in mean reaction time (ms) between
the first five minutes and last five minutes of the PVT in Baseline, Placebo, and
Caffeine conditions. Scores represented as mean ± SD
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